• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体(EGFR)突变的肺癌作为李-佛美尼综合征患者的继发肿瘤:病例报告

EGFR-mutated lung cancer as a secondary neoplasm in a patient with Li-Fraumeni syndrome: case report.

作者信息

Cortés Valenzuela Daniela Cristina, Vega Medina Pablo Andrés, Palma García Francisco José, Castillo-Fernandez Omar

机构信息

School of Medicine, University of Panama, Panama City, Panama.

Department of Medical Oncology, National Oncologic Institute, Panama City, Panama.

出版信息

AME Case Rep. 2024 Jun 14;8:76. doi: 10.21037/acr-23-206. eCollection 2024.

DOI:10.21037/acr-23-206
PMID:39091538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11292096/
Abstract

BACKGROUND

Li-Fraumeni syndrome (LFS) is a rare hereditary disorder caused by mutations in the tumor protein p53 (). It causes a predisposition for the development of multiple malignancies, primarily including breast cancers, sarcomas, and central nervous system tumors. There are a few cases reported in the literature of patients with LFS presenting with an epidermal growth factor receptor (EGFR) mutated lung cancer. Still, it has been suggested that there may be an association between the pathogenic variant and lung cancer with EGFR mutation in somatic cells.

CASE DESCRIPTION

A 47-year-old non-smoker woman with LFS with a history of multiple tumors, including bilateral breast cancer, pecoma, and sarcoma. In one of her computed tomography, a lesion in the lingula of the lung was detected. It was biopsied, which diagnosed lung adenocarcinoma, and genetic studies detected an EGFR exon 19 deletion. She was treated with a left inferior lobectomy, followed by pemetrexed and cisplatin.

CONCLUSIONS

The association between and lung cancer with EGFR mutation has been suggested in case reports. Studies in lung cancer cell lines have shown a link between TP53 mutation and EGFR overexpression. Nonetheless, as more cases are reported, further research is needed to comprehend the interrelation between these two pathologies and the risk posed by LFS to the emergence of EGFR-mutated lung cancer.

摘要

背景

李-佛美尼综合征(LFS)是一种由肿瘤蛋白p53突变引起的罕见遗传性疾病。它会导致多种恶性肿瘤的易感性增加,主要包括乳腺癌、肉瘤和中枢神经系统肿瘤。文献中报道了少数LFS患者出现表皮生长因子受体(EGFR)突变的肺癌病例。不过,有人提出体细胞中的致病变体与EGFR突变的肺癌之间可能存在关联。

病例描述

一名47岁不吸烟的LFS女性患者,有多种肿瘤病史,包括双侧乳腺癌、胚性癌和肉瘤。在她的一次计算机断层扫描中,发现肺部舌叶有一个病灶。对其进行活检,诊断为肺腺癌,基因研究检测到EGFR外显子19缺失。她接受了左下肺叶切除术,随后接受培美曲塞和顺铂治疗。

结论

病例报告中已提出[此处原文有缺失内容]与EGFR突变的肺癌之间的关联。对肺癌细胞系的研究表明TP53突变与EGFR过表达之间存在联系。尽管如此,随着更多病例的报道,需要进一步研究以了解这两种病理之间的相互关系以及LFS对EGFR突变肺癌发生所构成的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2130/11292096/a33b1501693f/acr-08-23-206-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2130/11292096/a33b1501693f/acr-08-23-206-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2130/11292096/a33b1501693f/acr-08-23-206-f1.jpg

相似文献

1
EGFR-mutated lung cancer as a secondary neoplasm in a patient with Li-Fraumeni syndrome: case report.表皮生长因子受体(EGFR)突变的肺癌作为李-佛美尼综合征患者的继发肿瘤:病例报告
AME Case Rep. 2024 Jun 14;8:76. doi: 10.21037/acr-23-206. eCollection 2024.
2
Molecular diagnosis and clinical outcome of a lung cancer patient with -E285K mutated Li-Fraumeni syndrome harboring a somatic -KDD mutation.一名患有携带体细胞-KDD突变的-E285K突变型李-弗劳梅尼综合征肺癌患者的分子诊断及临床结果
Am J Transl Res. 2020 Oct 15;12(10):6689-6693. eCollection 2020.
3
Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.2019 年 1.1 版李-佛美尼综合征医学指南
Int J Clin Oncol. 2021 Dec;26(12):2161-2178. doi: 10.1007/s10147-021-02011-w. Epub 2021 Oct 11.
4
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome.非小细胞肺癌和李-佛美尼综合征患者中体细胞致癌驱动基因改变的高发生率。
J Thorac Oncol. 2020 Jul;15(7):1232-1239. doi: 10.1016/j.jtho.2020.03.005. Epub 2020 Mar 14.
5
Epidermal Growth Factor Receptor-mutated Lung Cancer as the Initial Manifestation of Germline TP53 Mutation Associated Cancer.表皮生长因子受体突变型肺癌作为种系TP53突变相关癌症的初始表现
Cureus. 2018 Mar 30;10(3):e2395. doi: 10.7759/cureus.2395.
6
EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.表皮生长因子受体(EGFR)突变型肺腺癌与李-佛美尼综合征:两例报告并文献复习
Lung Cancer. 2015 Jan;87(1):80-4. doi: 10.1016/j.lungcan.2014.11.005. Epub 2014 Nov 20.
7
Case Report : Li-Fraumeni Syndrome with Central Nervous System Tumors in Two Siblings.病例报告:两兄妹均患李-佛美尼综合征合并中枢神经系统肿瘤。
BMC Pediatr. 2021 Dec 27;21(1):588. doi: 10.1186/s12887-021-03070-8.
8
A case series of non-small cell lung cancer patients with or exon 20 insertion in Li Fraumeni syndrome.Li Fraumeni 综合征中存在外显子 20 插入的非小细胞肺癌患者的病例系列。
Tumori. 2024 Dec;110(6):NP5-NP10. doi: 10.1177/03008916241255485. Epub 2024 May 23.
9
Correlation between choroid plexus carcinoma and Li-Fraumeni syndrome: implications of TP53 mutations and management strategies-a case-based narrative review.脉络丛癌与李-弗劳梅尼综合征的相关性:TP53突变的影响及管理策略——基于病例的叙述性综述
Childs Nerv Syst. 2024 Jun;40(6):1699-1705. doi: 10.1007/s00381-024-06313-y. Epub 2024 Feb 6.
10
A dual biomarker in non-small cell lung cancer that predicts Li Fraumeni syndrome : Lung cancer and Li Fraumeni.非小细胞肺癌中的双重生物标志物可预测 Li Fraumeni 综合征:肺癌与 Li Fraumeni。
Fam Cancer. 2024 Nov;23(4):469-471. doi: 10.1007/s10689-024-00418-8. Epub 2024 Sep 5.

本文引用的文献

1
The Clinical and Molecular Profile of Lung Cancer Patients Harboring the R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis.在巴西癌症中心携带 R337H 种系变异的肺癌患者的临床和分子特征:可能的致癌机制。
Int J Mol Sci. 2023 Oct 10;24(20):15035. doi: 10.3390/ijms242015035.
2
[Li-Fraumeni syndrome].[李-弗劳梅尼综合征]
Radiologie (Heidelb). 2022 Dec;62(12):1026-1032. doi: 10.1007/s00117-022-01071-x. Epub 2022 Sep 27.
3
Distinct NSCLC Variants in a Family With Li-Fraumeni Syndrome: Case Report.
李-弗劳梅尼综合征家族中的非小细胞肺癌不同变体:病例报告
JTO Clin Res Rep. 2022 Jun 25;3(8):100368. doi: 10.1016/j.jtocrr.2022.100368. eCollection 2022 Aug.
4
Lung Cancer in Li-Fraumeni Syndrome.李-弗劳梅尼综合征中的肺癌
JCO Precis Oncol. 2021 Mar 23;5. doi: 10.1200/PO.20.00468. eCollection 2021.
5
Molecular diagnosis and clinical outcome of a lung cancer patient with -E285K mutated Li-Fraumeni syndrome harboring a somatic -KDD mutation.一名患有携带体细胞-KDD突变的-E285K突变型李-弗劳梅尼综合征肺癌患者的分子诊断及临床结果
Am J Transl Res. 2020 Oct 15;12(10):6689-6693. eCollection 2020.
6
Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study.李-佛美尼综合征的放射治疗与第二原发恶性肿瘤:遗传性癌症登记研究。
Cancer Med. 2020 Nov;9(21):7954-7963. doi: 10.1002/cam4.3427. Epub 2020 Sep 15.
7
Lung adenocarcinoma in a patient with Li-Fraumeni syndrome bearing a novel germ-line mutation, TP53R333Vfs*12.李-佛美尼综合征患者的肺腺癌,携带一种新型种系突变,TP53R333Vfs*12。
Jpn J Clin Oncol. 2020 Sep 28;50(10):1214-1217. doi: 10.1093/jjco/hyaa095.
8
Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.Li-Fraumeni 综合征患者接受乳腺癌辅助放疗后放射性恶性肿瘤的发生频率。
Breast Cancer Res Treat. 2020 May;181(1):181-188. doi: 10.1007/s10549-020-05612-7. Epub 2020 Apr 3.
9
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome.非小细胞肺癌和李-佛美尼综合征患者中体细胞致癌驱动基因改变的高发生率。
J Thorac Oncol. 2020 Jul;15(7):1232-1239. doi: 10.1016/j.jtho.2020.03.005. Epub 2020 Mar 14.
10
High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant.携带TP53 p.R337H变异的巴西患者肺腺癌中EGFR突变的高发生率
Clin Lung Cancer. 2020 Mar;21(2):e37-e44. doi: 10.1016/j.cllc.2019.11.012. Epub 2019 Nov 28.